Traphaco JSC - Asset Resilience Ratio
Traphaco JSC (TRA) has an Asset Resilience Ratio of 22.64% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Traphaco JSC (TRA) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Traphaco JSC's Asset Resilience Ratio has changed over time. See shareholders equity of Traphaco JSC for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Traphaco JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TRA market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 0% |
| Short-term Investments | ₫529.51 Billion | 22.64% |
| Total Liquid Assets | ₫529.51 Billion | 22.64% |
Asset Resilience Insights
- Good Liquidity Position: Traphaco JSC maintains a healthy 22.64% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Traphaco JSC Industry Peers by Asset Resilience Ratio
Compare Traphaco JSC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 9.09% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.02% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for Traphaco JSC (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Traphaco JSC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.64% | ₫529.51 Billion ≈ $20.12 Million |
₫2.34 Trillion ≈ $88.88 Million |
-1.42pp |
| 2024-12-31 | 24.06% | ₫521.79 Billion ≈ $19.82 Million |
₫2.17 Trillion ≈ $82.41 Million |
+4.52pp |
| 2023-12-31 | 19.54% | ₫415.03 Billion ≈ $15.77 Million |
₫2.12 Trillion ≈ $80.70 Million |
+1.68pp |
| 2022-12-31 | 17.86% | ₫324.33 Billion ≈ $12.32 Million |
₫1.82 Trillion ≈ $69.01 Million |
+1.15pp |
| 2021-12-31 | 16.70% | ₫285.13 Billion ≈ $10.83 Million |
₫1.71 Trillion ≈ $64.86 Million |
+10.19pp |
| 2020-12-31 | 6.51% | ₫107.49 Billion ≈ $4.08 Million |
₫1.65 Trillion ≈ $62.72 Million |
+5.59pp |
| 2019-12-31 | 0.92% | ₫14.50 Billion ≈ $550.91K |
₫1.57 Trillion ≈ $59.71 Million |
-- |
About Traphaco JSC
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more